Taiwan Speciality Chemicals Corporation (TPEX: 4772)
Taiwan
· Delayed Price · Currency is TWD
169.50
-3.00 (-1.74%)
Oct 11, 2024, 1:30 PM CST
Taiwan Speciality Chemicals Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 751.68 | 553.52 | 532.28 | 515.67 | 416.63 | 162.14 |
Revenue Growth (YoY) | 69.69% | 3.99% | 3.22% | 23.77% | 156.96% | - |
Cost of Revenue | 420.04 | 343.31 | 278.27 | 254.5 | 289.14 | 244.72 |
Gross Profit | 331.65 | 210.21 | 254.01 | 261.17 | 127.49 | -82.58 |
Selling, General & Admin | 60.3 | 54.12 | 57.03 | 46.99 | 56.32 | 46.43 |
Research & Development | 17.83 | 18.31 | 26.19 | 18.87 | 5.11 | 3.27 |
Operating Expenses | 78.13 | 72.44 | 83.22 | 65.85 | 61.42 | 49.7 |
Operating Income | 253.51 | 137.78 | 170.79 | 195.31 | 66.07 | -132.28 |
Interest Expense | -0 | -0 | -0.13 | -2.35 | -6.75 | -8.56 |
Interest & Investment Income | 2.63 | 1.11 | 0.55 | 0.01 | 0.27 | 0.56 |
Earnings From Equity Investments | - | - | - | - | - | -0 |
Currency Exchange Gain (Loss) | 3.52 | -2.43 | 2.42 | -1.19 | -5.57 | -0.6 |
Other Non Operating Income (Expenses) | 2.89 | 2.79 | 6.72 | 1.33 | 1.4 | -9.05 |
EBT Excluding Unusual Items | 262.54 | 139.25 | 180.35 | 193.12 | 55.41 | -149.93 |
Gain (Loss) on Sale of Assets | 0.03 | -0.07 | -2.74 | 0.27 | 0.13 | -0.1 |
Asset Writedown | 0.02 | 0.02 | 9.86 | - | -145.33 | - |
Other Unusual Items | - | - | - | - | -16.12 | - |
Pretax Income | 262.59 | 139.2 | 187.47 | 194.45 | -93.1 | -150.03 |
Income Tax Expense | -16.45 | -16.45 | -20.5 | - | - | - |
Net Income | 279.05 | 155.65 | 207.97 | 194.45 | -93.1 | -150.03 |
Net Income to Common | 279.05 | 155.65 | 207.97 | 194.45 | -93.1 | -150.03 |
Net Income Growth | 188.26% | -25.16% | 6.96% | - | - | - |
Shares Outstanding (Basic) | 138 | 138 | 138 | 138 | 138 | 138 |
Shares Outstanding (Diluted) | 139 | 139 | 139 | 139 | 138 | 138 |
Shares Change (YoY) | 0.16% | -0.06% | 0.07% | 0.33% | 0.43% | - |
EPS (Basic) | 2.02 | 1.13 | 1.50 | 1.41 | -0.67 | -1.09 |
EPS (Diluted) | 2.00 | 1.12 | 1.50 | 1.40 | -0.67 | -1.09 |
EPS Growth | 185.47% | -25.33% | 7.14% | - | - | - |
Free Cash Flow | 392.55 | 133.76 | 206.29 | 302.33 | 238.82 | -74.39 |
Free Cash Flow Per Share | 2.83 | 0.96 | 1.49 | 2.18 | 1.73 | -0.54 |
Dividend Per Share | 1.000 | 1.000 | 0.680 | 0.650 | 4.280 | - |
Dividend Growth | 47.06% | 47.06% | 4.62% | -84.81% | - | - |
Gross Margin | 44.12% | 37.98% | 47.72% | 50.65% | 30.60% | -50.93% |
Operating Margin | 33.73% | 24.89% | 32.09% | 37.88% | 15.86% | -81.58% |
Profit Margin | 37.12% | 28.12% | 39.07% | 37.71% | -22.35% | -92.53% |
Free Cash Flow Margin | 52.22% | 24.16% | 38.76% | 58.63% | 57.32% | -45.88% |
EBITDA | 365.71 | 256.69 | 314.39 | 327.5 | 227.89 | 61.37 |
EBITDA Margin | 48.65% | 46.37% | 59.06% | 63.51% | 54.70% | 37.85% |
D&A For EBITDA | 112.2 | 118.91 | 143.6 | 132.19 | 161.83 | 193.65 |
EBIT | 253.51 | 137.78 | 170.79 | 195.31 | 66.07 | -132.28 |
EBIT Margin | 33.73% | 24.89% | 32.09% | 37.88% | 15.86% | -81.58% |
Source: S&P Capital IQ. Standard template. Financial Sources.